ClinVar Miner

Submissions for variant NM_020433.5(JPH2):c.1282C>T (p.Gln428Ter)

gnomAD frequency: 0.00004  dbSNP: rs199896820
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Blueprint Genetics RCV000208272 SCV000263958 uncertain significance Primary dilated cardiomyopathy 2015-11-24 criteria provided, single submitter clinical testing
SIB Swiss Institute of Bioinformatics RCV001572616 SCV002319194 uncertain significance Cardiomyopathy, dilated, 2E 2022-02-23 criteria provided, single submitter curation This variant is interpreted as a variant of uncertain significance for Cardiomyopathy, dilated, 2E, autosomal recessive. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); Predicted nullvariant in a gene where LOF is a known mechanism of disease (PVS1 downgraded to moderate).
Fulgent Genetics, Fulgent Genetics RCV002478749 SCV002781700 uncertain significance Hypertrophic cardiomyopathy 17; Cardiomyopathy, dilated, 2E 2021-07-13 criteria provided, single submitter clinical testing
Ambry Genetics RCV003298273 SCV004000708 uncertain significance Cardiovascular phenotype 2023-05-17 criteria provided, single submitter clinical testing The p.Q428* variant (also known as c.1282C>T), located in coding exon 3 of the JPH2 gene, results from a C to T substitution at nucleotide position 1282. This changes the amino acid from a glutamine to a stop codon within coding exon 3. This variant has been detected in the homozygous state in a pediatric case with severe dilated cardiomyopathy requiring transplant; heterozygous relatives were indicated as unaffected (Vasilescu C et al. J Am Coll Cardiol, 2018 Nov;72:2324-2338). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Although biallelic loss of function alterations in JPH2 have been associated with autosomal recessive dilated cardiomyopathy, haploinsufficiency for JPH2 has not been clearly established as a mechanism of disease for autosomal dominant hypertrophic cardiomyopathy. Based on the supporting evidence, this variant is expected to be causative of autosomal recessive dilated cardiomyopathy when present along with a second pathogenic variant on the other allele; however, its clinical significance for autosomal dominant hypertrophic cardiomyopathy is unclear.
OMIM RCV001572616 SCV001797289 pathogenic Cardiomyopathy, dilated, 2E 2021-08-18 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.